Person reviewing medical documents and funding forms in contemplative moment with natural lighting
Published on May 15, 2024

The key to overturning a funding denial is to stop arguing your case as a patient and start building it like a lawyer, using the ICB’s own rules against them.

  • Your case must prove ‘clinical exceptionality’—demonstrating you are significantly different from the average patient with your condition.
  • A common mistake is focusing on your need for the treatment, rather than pre-emptively answering the panel’s hidden questions about evidence and setting precedents.

Recommendation: Immediately shift your focus from emotional appeals to strategic evidence gathering. Document every interaction, challenge every refusal, and build a case so robust the ICB has no choice but to approve it.

Receiving a letter from your Integrated Care Board (ICB) stating that funding for a recommended treatment has been denied is a crushing blow. It feels profoundly unfair, especially when you hear stories of the same drug or procedure being available in other parts of the UK. The immediate, understandable reaction is one of anger and a desire to simply tell the board how much you need this treatment. But this is the first and most critical mistake.

To successfully appeal a funding decision, you must undergo a radical shift in mindset. Complaining about the injustice of the “postcode lottery” or explaining your suffering, while valid, is ineffective. The system is not designed to respond to emotional pleas; it is a bureaucratic process governed by strict criteria, legal precedents, and budgetary constraints. This guide is not about how to write a complaint. It’s about how to build an irrefutable clinical and legal case.

To win, you must stop thinking like a patient and start thinking like the panel that refused you. You must understand their framework, anticipate their objections, and provide them with the specific evidence they need to say “yes” without fear of “opening the floodgates.” This requires a tactical, evidence-based approach, turning your frustration into a methodical strategy. We will deconstruct this process, giving you the tools to challenge the decision on their terms, and win.

This article provides a step-by-step tactical plan to deconstruct the ICB’s decision-making process and build a powerful appeal. The following sections will guide you through the critical components of a successful funding challenge.

Why Can Patients in Scotland Get Drugs That Are Banned in England?

The “postcode lottery” is one of the most frustrating aspects of NHS care. The knowledge that a life-changing drug is available in Scotland or Wales but denied to you in England feels like a cruel injustice. This disparity arises because different bodies assess drugs for use in different parts of the UK. In England, the National Institute for Health and Care Excellence (NICE) makes these decisions, while in Scotland, it’s the Scottish Medicines Consortium (SMC).

While their goals are similar, their methodologies and cost-effectiveness thresholds can differ. Interestingly, a 2024 comparative study found that overall approval rates for cancer drugs were similar, with a 90.5% SMC approval rate versus 89.4% for NICE, and a discordance of only 12.6%. This suggests the systems are more aligned than they appear, but that small percentage of discordance can have a massive impact on specific patient groups.

Case Study: The Fampridine Disparity

A stark example of this is Fampridine, a drug that can significantly improve walking ability for people with Multiple Sclerosis. It has been approved for use on the NHS in Scotland, Wales, and Northern Ireland. However, it remains largely unavailable on the NHS in England despite clear evidence of its clinical benefits. This is a classic case where a patient’s access to a transformative treatment is determined solely by their postcode, highlighting the very real consequences of these divergent appraisal systems.

Understanding this is tactically important. While pointing out the disparity can form part of the narrative of your appeal, your case cannot rest on it. An ICB panel in England is bound by NICE guidance, not SMC decisions. Your appeal must be built on the rules of the English system, specifically the concept of clinical exceptionality.

How to Build a ‘Clinical Exceptionality’ Case for Your Funding Appeal

This is the heart of your appeal. ‘Clinical exceptionality’ is the legal key that unlocks funding for treatments not routinely available. It is a high bar to clear. You are not trying to prove that you *need* the treatment; you are proving that you are significantly different from the average group of patients with the same condition, and that because of this difference, you will gain significantly more benefit from the treatment.

This is not about your personal circumstances (e.g., having young children). It is about your specific clinical presentation. Does your version of the disease have a rare genetic marker? Have you had a unique and documented adverse reaction to all standard treatments? This is where your uniqueness is a strength.

As the UK courts have affirmed, exceptionality can be established through a combination of factors. In one landmark legal precedent, the court found that the claimant was exceptional because her form of narcolepsy was rare, her failure to respond to standard treatments was also rare, and her health was rapidly deteriorating. This combination created a compelling case that she was not like other patients in the comparator group.

Your Action Plan: The Four Pillars of a Clinical Exceptionality Case

  1. Demonstrate that you have clinical features that make you significantly different from other patients with the same clinical condition and at the same stage of progression.
  2. Prove you are likely to gain significantly more clinical benefit from the intervention than might be expected for the average patient with that condition.
  3. Show that there is NOT a group of patients with the same or similar clinical circumstances who could also make the same request (this is to counter the “floodgates” argument).
  4. Document that all standard, commissioned care options have either failed, been ruled out, or are contraindicated for specific, documented clinical reasons unique to you.

Your entire evidence-gathering process must be geared towards proving these four points. Your clinician is your critical ally in this, as they must articulate these points in the Individual Funding Request (IFR) application.

NICE Guidelines vs Clinical Judgment: When Can a Doctor Ignore the Rules?

A common reason for refusal is that the requested treatment is not recommended by NICE. This can feel like a dead end, but it isn’t. NICE guidelines are exactly that—guidance, not law. This is a crucial distinction that can be leveraged in your appeal. Your doctor’s clinical judgment remains paramount.

In fact, NICE itself explicitly states this. Their own official principles clarify that guidance does not override the individual responsibility of health professionals to make appropriate decisions based on the unique circumstances of an individual patient, in consultation with that patient. This is a powerful statement to include in your appeal documentation. It shows the panel that you understand the rules better than they might expect.

guidance does not override the individual responsibility of health professionals to make appropriate decisions according to the circumstances of the individual patient in consultation with the patient and/or their guardian/carer

– NICE, Official NICE guidance principles

The legal protection for a doctor deviating from guidelines is rooted in a principle known as the “Bolam test.” In simple terms, it means a doctor is not considered negligent if they can show they acted in accordance with a practice accepted as proper by a responsible body of medical opinion. Legally, under the established Bolam test, this means that even if another group of doctors would have followed the NICE guidance, the deviation is defensible as long as a credible group of specialists supports it. Therefore, your task is to help your clinician gather evidence (e.g., from other specialists, clinical studies, conference papers) that supports their clinical judgment to deviate from the standard path for you.

The Common Complaint Letter Mistake That Gets Your Case Dismissed

When you sit down to write your appeal letter, your instinct is to pour your heart out. You want to describe your pain, the impact on your family, and your desperate need for the treatment. This is the single most common and devastating mistake. It focuses entirely on your perspective and fails to address the three hidden questions every IFR panel is silently asking.

An IFR panel is a group of clinicians, commissioners, and lay members whose job is to manage a finite budget for an entire population. They are not trying to be cruel; they are trying to be equitable with limited resources. To do this, they use a rigid framework. Your letter will be dismissed if it doesn’t speak their language and answer their questions directly. You must structure your appeal to pre-emptively answer these three questions:

  • Question 1 – Why you? (Exceptionality): This is the clinical exceptionality argument. What makes you clinically different from every other patient with this condition who might also want this treatment? Your letter must lead with this, supported by clinical evidence.
  • Question 2 – Why this? (Evidence): Why this specific, unapproved treatment? Is there evidence you will gain a much greater clinical benefit than the average patient? Have all cheaper, standard options been exhausted or proven unsuitable for you specifically?
  • Question 3 – What are the floodgates? (Precedent): This is the question they worry about most. If we approve this for you, will we have to approve it for a whole new group of patients? Your appeal must show why your case is so unique that it will *not* set a precedent.

The fatal mistake is writing a letter that only answers the “why me” from an emotional standpoint, while ignoring the clinical “why you,” the evidential “why this,” and the financial “floodgates” questions. A powerful appeal letter is a dispassionate, evidence-based document that systematically dismantles any reason the panel could have for saying no.

When to Demand a Specialist Referral: The 3 Red Flags GPs Shouldn’t Ignore

Your GP is your primary ally, but they are a generalist. To build a robust case for “clinical exceptionality,” you almost always need detailed evidence from a specialist consultant who is an expert in your specific condition. A letter from a world-renowned expert carries far more weight with an IFR panel than a simple request from a GP. But what if your GP is reluctant to refer you?

You have the right to request a referral. While a GP can refuse if they don’t believe it’s clinically necessary, you must be prepared to challenge this, especially if you tick certain red flag boxes. The key red flags are: your condition is worsening despite standard treatment, your symptoms are unusual (atypical), or a potential diagnosis carries a high risk if missed. In these situations, a specialist opinion is not just helpful, it’s essential.

Case Study: The Importance of Specialist Evidence

In a crucial case involving a child with Phenylketonuria (PKU), who also had autism and learning difficulties, the standard diet-based treatment was unworkable. It was the detailed specialist evidence, proving that standard treatments were clinically unsuitable for this specific patient, that was instrumental in securing funding for an alternative treatment. This case demonstrates that when the standard pathway fails, specialist evidence is no longer a luxury—it’s a necessity to prevent severe harm.

If your request for a specialist referral is refused, you must immediately switch to evidence-gathering mode. Do not leave the consultation empty-handed. You must create a paper trail. Follow this protocol without fail:

Action Plan: Protocol for a Refused Specialist Referral

  1. During the consultation, state clearly and formally: “I am formally requesting a referral to [specific specialist] for [specific clinical reason].”
  2. If refused, immediately request: “Please can you document my formal request and your clinical reason for refusal in my medical notes today.”
  3. Follow up with a formal, dated letter or email to the practice manager within 48 hours, politely restating your request, the GP’s refusal, and asking for a written response with the clinical rationale.
  4. Retain all copies of this correspondence. This documentation is now crucial evidence for a formal complaint or as part of your IFR application to show you have exhausted all avenues.

This process is not about being confrontational; it’s about being methodical. It shows the system that you are a serious, well-informed patient who will not be easily dismissed.

How to Apply for Funding for ‘Not Routine’ Treatments via Your CCG

Once you and your clinician have gathered the evidence for clinical exceptionality, the next step is the formal application. This process is known as an Individual Funding Request (IFR). It’s important to note that Clinical Commissioning Groups (CCGs) have now been replaced by Integrated Care Boards (ICBs), but the IFR process remains fundamentally the same. Your clinician—usually your GP or specialist consultant—submits the application on your behalf. You cannot submit it yourself.

Your role is to act as the project manager for your own case. You must ensure your clinician has all the evidence—clinic letters, test results, your documented history of treatment failures—organised and ready. The quality of the application is paramount. A complete, well-argued application can receive a decision relatively quickly. Indeed, according to NHS England guidance, ICBs should make a decision within 30 working days of receiving a complete application.

One critical point of confusion is the difference between an IFR and a request for “service development.” An IFR is for you, as an individual exception. Service development is when there is evidence that a whole group (cohort) of patients could benefit, which should prompt the ICB to consider commissioning the service for everyone. The panel will dismiss your IFR if they believe it’s actually a case for service development. Understanding the difference is vital.

When to Submit an IFR vs. Request Service Development
Scenario IFR Route Service Development Route
Patient uniqueness No other patients with similar clinical circumstances expected to benefit in a similar way Evidence that other patients with the same condition could derive similar benefit
Timing requirement Individual patient needs urgent treatment decision Treatment could be part of commissioning plan for future patient cohort
Evidence threshold Must demonstrate clinical exceptionality compared to others with same condition Must demonstrate clinical and cost-effectiveness for the patient group
Decision maker IFR Panel reviews individual case Commissioning policy development process

This table, based on guidance from ICBs like Lancashire and South Cumbria ICB, makes it clear: your IFR must prove your uniqueness to avoid being pushed into the slower, broader service development process.

Key Takeaways

  • Success hinges on proving ‘clinical exceptionality,’ not emotional need. You must be demonstrably different from the average patient.
  • Your appeal letter must pre-emptively answer the panel’s three hidden questions: Why you (exceptionality)? Why this (evidence)? And what about the floodgates (precedent)?
  • Document every conversation, request, and refusal. A solid paper trail is your most powerful weapon when challenging the system.

What Count as ‘Reasonable Adjustments’ for Chronic Fatigue in the Office?

The fight for your health often extends beyond the clinic and into the workplace. For many chronic conditions, debilitating fatigue is a primary symptom. Under the Equality Act 2010, if your condition has a ‘substantial and long-term’ negative effect on your ability to do normal daily activities, your employer has a legal duty to make ‘reasonable adjustments’ to help you manage your work.

For chronic fatigue, these adjustments are not about ‘making life easy’; they are about enabling you to do your job effectively. They are practical changes to the work environment or your working pattern. The key is to be proactive and suggest specific, workable solutions to your employer. Generic complaints about being tired are less effective than a concrete proposal.

Examples of reasonable adjustments for chronic fatigue can include:

  • Flexible Working: Adjusting start and finish times to avoid peak travel times or to align with your energy levels.
  • Phased Return to Work: Gradually increasing your hours after a period of sickness absence.
  • Hybrid/Home Working: Allowing you to work from home on certain days to conserve the energy spent commuting.
  • Re-allocation of Duties: Temporarily or permanently swapping physically or mentally draining tasks for other duties.
  • Additional Breaks: Allowing for short, scheduled rest periods during the day to manage energy levels.
  • Ergonomic Equipment: Providing a supportive chair or other equipment to reduce physical strain that contributes to fatigue.

The employer is only obliged to make adjustments that are ‘reasonable’. This depends on the size and resources of the employer and the practicality of the change. Presenting your request with a doctor’s note supporting the need for these adjustments will significantly strengthen your position.

Your Rights at Work: Managing a Chronic Condition Without Getting Fired

The anxiety of managing a chronic health condition is often compounded by the fear of losing your job. It’s vital to understand that UK law provides significant protections. The battle for your health and the security of your employment are intrinsically linked, and knowledge of your rights is your shield.

The cornerstone of this protection is the Equality Act 2010. If your chronic condition meets the definition of a disability (a physical or mental impairment that has a ‘substantial’ and ‘long-term’ negative effect on your ability to carry out normal day-to-day activities), you are protected from discrimination. This means your employer cannot treat you less favourably because of your condition and, as discussed, must make reasonable adjustments.

It is unlawful for an employer to dismiss you or select you for redundancy simply because you have a chronic condition. Any such action could be grounds for a claim of unfair dismissal and/or disability discrimination. The employer must be able to show they have followed a fair process, fully considered all reasonable adjustments, and have a legitimate, non-discriminatory reason for their decision. Your fight to get the right medical treatment through an IFR can even be relevant here; it demonstrates you are proactively managing your condition to maximise your ability to work.

Protecting yourself involves the same principles as appealing an ICB decision: documentation and proactive communication. Keep records of all conversations with HR and your line manager. Follow up verbal agreements with emails. Provide updates from your doctor. This creates a clear record that you are engaging in good faith and that your employer is aware of their legal obligations. This professional approach not only strengthens your legal position but also often fosters a more supportive relationship with your employer, who may simply be unaware of their duties.

Ultimately, navigating the NHS and protecting your rights at work requires you to become the CEO of your own health. It demands strategy, persistence, and meticulous record-keeping. By taking control of the process and arming yourself with knowledge, you shift from being a passive recipient of decisions to an active agent in shaping your own future. Begin today by organising your medical evidence and drafting a plan based on the principles in this guide.

Written by Dr. Sarah Jenkins, Dr. Sarah Jenkins is a seasoned healthcare consultant and former Director of Operations for a major NHS Trust. She holds a PhD in Health Policy from the London School of Economics and specializes in navigating the complexities of the UK healthcare system. Currently, she advises patients on funding appeals, data privacy rights, and choosing between NHS and private pathways.